红色生物技术市场－全球产业规模、份额、趋势、竞争、机会和预测，按产品类型、应用、最终用户、地区和竞争细分，2020-2030 年

2024年，全球红色生物技术市场规模为4,213.2亿美元，预计2030年将达到7,741.5亿美元，预测期内复合年增长率为10.67%。市场成长的驱动力包括基因工程的不断进步、针对危及生命的疾病的新型疗法日益增长的需求以及精准医疗的蓬勃发展。红色生物技术涉及利用活细胞和生物分子製程进行治疗和诊断，包括生产疫苗、基因疗法、诊断试剂和生物製药。随着个人化治疗和针对特定疾病的疗法需求不断增长，红色生物技术产业在已开发市场和新兴市场都有望显着成长。

关键市场驱动因素

慢性病和罕见疾病管理对生物製药的需求不断增长

主要市场挑战

开发成本高且监管要求复杂

主要市场趋势

个人化医疗和基因组学疗法的扩展

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：红色生物技术市场展望。

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依产品类型（诊断试剂、人用疫苗、血液製品、基因重组药物及其他）
  • 按应用（生物製药生产、基因治疗、基因检测、药物基因体学、药物发现等）
  • 按最终用户（製药和生物技术公司、CMO 和 CRO、研究机构等）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：亚太红色生物技术市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国 。
  • 印度 。
  • 韩国
  • 日本
  • 澳洲

第七章：欧洲红色生物技术市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：北美红色生物技术市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第九章：南美洲红色生物技术市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东与非洲红色生物技术市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 併购
• 产品开发

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品/服务的威胁

第 14 章：全球红色生物技术市场：SWOT 分析

第 15 章：竞争格局

• Pfizer, Inc.
• Takeda Pharmaceutical Company Limited
• Gilead Sciences
• Regeneron Pharmaceuticals, Inc.
• F. Hoffmann-La Roche Ltd.
• Bruker Corporation
• Merck KGaA
• Celgene Corporation
• Amgen Inc.
• Biogen Inc.

第 16 章：策略建议

第17章调查会社について・免责事项

The Global Red Biotechnology Market was valued at USD 421.32 billion in 2024 and is projected to reach USD 774.15 billion by 2030, growing at a CAGR of 10.67% during the forecast period. Market growth is being driven by increasing advancements in genetic engineering, the growing need for novel therapeutics targeting life-threatening diseases, and the surge in precision medicine development. Red biotechnology involves the use of living cells and biomolecular processes for therapeutic and diagnostic applications, including the production of vaccines, gene therapies, diagnostic reagents, and biopharmaceuticals. As demand for personalized treatments and disease-specific therapies continues to expand, the red biotechnology sector is positioned for significant growth across both developed and emerging markets.

Key Market Drivers

Rising Demand for Biopharmaceuticals in Chronic and Rare Disease Management

The increasing prevalence of chronic and rare diseases is a major factor accelerating the demand for red biotechnology, especially in the development of biopharmaceuticals such as recombinant proteins, monoclonal antibodies, and gene therapies. These innovations are addressing unmet medical needs where traditional treatments fall short. According to the World Health Organization (WHO), chronic illnesses-including cancer, cardiovascular diseases, diabetes, and respiratory disorders-account for approximately 74% of all global deaths. In parallel, rare diseases impact over 300 million individuals worldwide. Red biotechnology plays a vital role in the development of precision therapies for these complex health conditions, driving investment and research in this field globally.

Key Market Challenges

High Development Costs and Complex Regulatory Requirements

A major challenge in the red biotechnology market is the substantial cost and complexity associated with developing advanced therapeutics such as gene therapies and biologics. The R&D process involves extensive clinical trials, strict regulatory compliance, and rigorous quality controls, often resulting in long timelines and high expenses. According to the U.S. Congressional Budget Office (CBO), the cost of developing a single biopharmaceutical product can exceed $2.6 billion, and innovations within red biotechnology frequently surpass this due to their technical intricacies. Regulatory bodies such as the FDA and EMA impose detailed requirements for safety, efficacy, and long-term monitoring, particularly for gene-editing therapies. The variability in regulatory frameworks across different countries adds further challenges to global product launches, impacting speed to market and operational efficiency.

Key Market Trends

Expansion of Personalized Medicine and Genomics-Based Therapies

A transformative trend in the red biotechnology market is the rapid advancement of personalized medicine and genomics-driven therapies. Personalized medicine involves tailoring treatments to individual patients based on genetic, environmental, and lifestyle factors. Red biotechnology is central to this trend through the development of targeted therapies, gene-editing tools, and molecular diagnostics. The widespread adoption of next-generation sequencing (NGS) and genomic profiling has enabled deeper understanding of disease mechanisms, supporting the creation of patient-specific treatment plans. The declining cost of genome sequencing-from nearly $100 million in 2001 to under $1,000 in 2024-has accelerated clinical integration of genomics, propelling growth in red biotechnology applications.

Key Market Players

• Pfizer, Inc.
• Takeda Pharmaceutical Company Limited
• Gilead Sciences
• Regeneron Pharmaceuticals, Inc.
• F. Hoffmann-La Roche Ltd.
• Bruker Corporation
• Merck KGaA
• Celgene Corporation
• Amgen Inc.
• Biogen Inc.

Report Scope:

In this report, the Global Red Biotechnology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Red Biotechnology Market, By Product Type:

• Diagnostic Reagents
• Human Vaccines
• Blood Products
• Gene Recombinant Drugs
• Others

Red Biotechnology Market, By Application:

• Biopharmaceutical Production
• Gene Therapy
• Genetic Testing
• Pharmacogenomics
• Drug Discovery
• Others

Red Biotechnology Market, By End-User:

• Pharmaceutical and Biotechnology Companies
• CMO & CRO
• Research Institute
• Others

Red Biotechnology Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Red Biotechnology Market.

Available Customizations:

Global Red Biotechnology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered.
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Red Biotechnology Market Outlook.

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Diagnostic Reagents, Human Vaccines, Blood Products, Gene Recombinant Drugs and Others)
  • 5.2.2. By Application (Biopharmaceutical Production, Gene Therapy, Genetic Testing, Pharmacogenomics, Drug Discovery, and Others)
  • 5.2.3. By End-User (Pharmaceutical and Biotechnology companies, CMO & CRO, Research Institute and Others)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. Asia-Pacific Red Biotechnology Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Application
  • 6.2.3. By End-User
  • 6.2.4. By Country
• 6.3. Asia-Pacific: Country Analysis
  • 6.3.1. China Red Biotechnology Market Outlook.
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End-User
  • 6.3.2. India Red Biotechnology Market Outlook.
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End-User
  • 6.3.3. South Korea Red Biotechnology Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End-User
  • 6.3.4. Japan Red Biotechnology Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Product Type
      • 6.3.4.2.2. By Application
      • 6.3.4.2.3. By End-User
  • 6.3.5. Australia Red Biotechnology Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Product Type
      • 6.3.5.2.2. By Application
      • 6.3.5.2.3. By End-User

7. Europe Red Biotechnology Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Application
  • 7.2.3. By End-User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Red Biotechnology Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End-User
  • 7.3.2. Germany Red Biotechnology Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End-User
  • 7.3.3. United Kingdom Red Biotechnology Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End-User
  • 7.3.4. Italy Red Biotechnology Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End-User
  • 7.3.5. Spain Red Biotechnology Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End-User

8. North America Red Biotechnology Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Application
  • 8.2.3. By End-User
  • 8.2.4. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Red Biotechnology Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End-User
  • 8.3.2. Mexico Red Biotechnology Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End-User
  • 8.3.3. Canada Red Biotechnology Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End-User

9. South America Red Biotechnology Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Application
  • 9.2.3. By End-User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Red Biotechnology Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End-User
  • 9.3.2. Argentina Red Biotechnology Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End-User
  • 9.3.3. Colombia Red Biotechnology Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End-User

10. Middle East and Africa Red Biotechnology Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Application
  • 10.2.3. By End-User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Red Biotechnology Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End-User
  • 10.3.2. Saudi Arabia Red Biotechnology Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End-User
  • 10.3.3. UAE Red Biotechnology Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products/Services

14. Global Red Biotechnology Market: SWOT Analysis

15. Competitive Landscape

• 15.1. Pfizer, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Takeda Pharmaceutical Company Limited
• 15.3. Gilead Sciences
• 15.4. Regeneron Pharmaceuticals, Inc.
• 15.5. F. Hoffmann-La Roche Ltd.
• 15.6. Bruker Corporation
• 15.7. Merck KGaA
• 15.8. Celgene Corporation
• 15.9. Amgen Inc.
• 15.10. Biogen Inc.

16. Strategic Recommendations

17. About Us & Disclaimer